Dantelabs
UK, GB · 1 known investors
Dante Labs provides clinical-grade whole genome sequencing services for individuals seeking genetic insights into hereditary disease risk, diagnostic clarity for unexplained symptoms, treatment optimization, and proactive health planning. The company delivers comprehensive genomic analysis as an alternative to limited consumer DNA tests, with results presented in 200+ physician-ready clinical reports.
Digital HealthMedical Devices